Talleyrand IntelligenceThe facts. Your judgement.

eHealth Q2 2026 — the filed record

CALL 2026-08-04 RECORD PUBLISHED 2026-08-18 FILING RECORD · TRANSCRIPT ANALYSIS PENDING
Why the Results ChangedExact source language · this is not analyst valuation logic
Media analysis
Media · post-earnings takeaway

“Medicare Advantage enrollment and submissions declined 44% in Q2, reflecting the deliberate reduction in marketing spend and the transition to the Lifetime Advisory model.”

Finance · via Yahoo FinancePost-earnings media analysisFinance · via Yahoo Finance 2026-08-08 ↗
Media analysis
Media · post-earnings takeaway

“The company expects further year-over-year declines in Q3 revenue and enrollment due to even greater marketing spend reductions.”

Finance · via Yahoo FinancePost-earnings media analysisFinance · via Yahoo Finance 2026-08-08 ↗
Media analysis
Media · post-earnings takeaway

“The model drives higher retention, higher ancillary cross-sell rates, and more favorable cash flow timing from ancillary products, all contributing to a stronger cash flow profile.”

Finance · via Yahoo FinancePost-earnings media analysisFinance · via Yahoo Finance 2026-08-08 ↗
Management
Management · earnings release

Derrick Duke · earnings statement

“Second quarter results were in line to slightly above our expectations and reflect the deliberate choices we made going into 2026.”
Derrick DukeChief Executive Officer8-K 2026-08-04 · EX-99.1 ↗
Target Changes — Why Not AvailableAction is public · model logic is not
Analyst action
Reported action · explanation unavailable

Deutsche Bank Maintains EHealth(EHTH.US) With Hold Rating, Cuts Target Price to $2

Why the target changed: not public. The linked report does not provide the analyst’s revised forecasts, valuation multiple, or assumptions. The results and guidance above may have informed the action, but the public record does not establish that connection.

Deutsche BankPost-earnings analyst actionMoomoo 2026-08-06 ↗
Sourced Takeaways5 takeaways · every bullet sourced
  1. Revenue was $33.6M; versus $60.8M a year earlier; FY guide $405.0M–$445.0M.
    Filed8-K 2026-08-04 · EX-99.1
  2. Net income was ($23.6M); versus ($17.4M) a year earlier; FY guide $8.0M–$25.0M.
    Filed8-K 2026-08-04 · EX-99.1
  3. Adjusted EBITDA was ($21.8M); versus ($14.1M) a year earlier; FY guide $55.0M–$75.0M.
    Filed8-K 2026-08-04 · EX-99.1
  4. Operating cash flow was ($5.0M); versus ($41.2M) a year earlier; FY guide ($10.0M)–$12.0M.
    Filed8-K 2026-08-04 · EX-99.1
  5. Diluted EPS (GAAP) was ($1.18); versus ($0.98) a year earlier.
    Filed8-K 2026-08-04 · EX-99.1
The NumbersReported · published precision · every figure sourced
MetricQ2 2026Prior yrYoYFY Guide
Revenue$33.6M$60.8M$405.0M–$445.0M
Net income($23.6M)($17.4M)$8.0M–$25.0M
Adjusted EBITDA($21.8M)($14.1M)$55.0M–$75.0M
Operating cash flow($5.0M)($41.2M)($10.0M)–$12.0M
Diluted EPS (GAAP)($1.18)($0.98)
CMS ROWS ARE GROUND TRUTH, INDEPENDENT OF COMPANY REPORTING · PRECISION PER BRAND SPEC
The DocumentsEverything this record is built from
The filing every figure on this page is read from.
8-K 2026-08-04 · EX-99.1